Quantitative analysis of adipose tissue in single transverse slices for estimation of volumes of relevant fat tissue compartments: A study in a large cohort of subjects at risk for type 2 diabetes by MRI with comparison to anthropometric data

Investigative Radiology

Volumn 45, Issue 12, 2010, Pages 788-794

  Schwenzer, Nina F ^a   MacHann, Jürgen ^a   Schraml, Christina ^a   Springer, Fabian ^a   Ludescher, Burkhard ^a   Stefan, Norbert ^a   Häring, Hans ^a   Fritsche, Andreas ^a   Claussen, Claus D ^a   Schick, Fritz ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Adipose tissue; Body mass index; MRI; Type 2 diabetes; Visceral adipose tissue; Waist to hip ratio

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; COHORT ANALYSIS; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FEMUR; HUMAN; HUMERUS; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OBESITY; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; UMBILICUS; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WHOLE BODY MRI;

EID: 78650677696     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181f10fe1     Document Type: Article

References (47)

1. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881-887.
2. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168: 1609-1616.
3. Gastaldelli A, Cusi K, Pettiti M, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology. 2007;133:496-506.
4. Hayashi T, Boyko EJ, McNeely MJ, et al. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes. 2008;57:1269-1275.
5. Thamer C, Machann J, Stefan N, et al. High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity (Silver Spring). 2007;15:531-538.
6. Boyko EJ, Fujimoto WY, Leonetti DL, et al. Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans. Diabetes Care. 2000;23:465-471.
7. Hayashi T, Boyko EJ, Leonetti DL, et al. Visceral adiposity and the prevalence of hypertension in Japanese Americans. Circulation. 2003;108:1718-1723.
8. Druet C, Baltakse V, Chevenne D, et al. Independent effect of visceral adipose tissue on metabolic syndrome in obese adolescents. Horm Res. 2008;70:22-28.
9. Gabriely I, Ma XH, Yang XM, et al. Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes. 2002;51:2951-2958.
10. Illouz F, Roulier V, Rod A, et al. Distribution of adipose tissue: quantification and relationship with hepatic steatosis and vascular profiles of type 2 diabetic patients with metabolic syndrome. Diabetes Metab. 2008;34:68-74.
11. Scherzer R, Shen W, Bacchetti P, et al. Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects. Am J Clin Nutr. 2008;87:1809-1817.
12. Jebb SA, Elia M. Techniques for the measurement of body composition: a practical guide. Int J Obes Relat Metab Disord. 1993;17:611-621.
13. Clarys JP, Provyn S, Marfell-Jones MJ. Cadaver studies and their impact on the understanding of human adiposity. Ergonomics. 2005;48:1445-1461.
14. Smith SR, Lovejoy JC, Greenway F, et al. Contributions of total body fat, abdominal subcutaneous adipose tissue compartments, and visceral adipose tissue to the metabolic complications of obesity. Metabolism. 2001;50:425-435.
15. Zhao B, Colville J, Kalaigian J, et al. Automated quantification of body fat distribution on volumetric computed tomography. J Comput Assist Tomogr. 2006;30:777-783.
16. Miyazaki Y, Glass L, Triplitt C, et al. Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab. 2002;283:E1135-E1143.
17. Janssen I, Heymsfield SB, Allison DB, et al. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr. 2002;75:683-688.
18. Kuk JL, Janiszewski PM, Ross R. Body mass index and hip and thigh circumferences are negatively associated with visceral adipose tissue after control for waist circumference. Am J Clin Nutr. 2007;85:1540-1544.
19. Goel K, Gupta N, Misra A, et al. Predictive equations for body fat and abdominal fat with DXA and MRI as reference in Asian Indians. Obesity (Silver Spring). 2008;16:451-456.
20. Poll L, Wittsack HJ, Willers R, et al. Correlation between anthropometric parameters and abdominal fat volumes assessed by a magnetic resonance imaging method in patients with diabetes. Diabetes Technol Ther. 2004;6: 844-849.
21. Siegel MJ, Hildebolt CF, Bae KT, et al. Total and intraabdominal fat distribution in preadolescents and adolescents: measurement with MR imaging. Radiology. 2007;242:846-856.
22. Ludescher B, Machann J, Eschweiler GW, et al. Correlation of fat distribution in whole body MRI with generally used anthropometric data. Invest Radiol. 2009;44:712-719.
23. Schwenzer NF, Machann J, Martirosian P, et al. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol. 2008;43:330-337.
24. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2:367-373.
25. Weckbach S, Findeisen HM, Schoenberg SO, et al. Systemic cardiovascular complications in patients with long-standing diabetes mellitus: comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography. Invest Radiol. 2009;44:242-250.
26. Machann J, Thamer C, Schnoedt B, et al. Standardized assessment of whole body adipose tissue topography by MRI. J Magn Reson Imaging. 2005;21: 455-462.
27. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116:39-48.
28. Gan SK, Kriketos AD, Poynten AM, et al. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res. 2003;11:1295-1305.
29. Taksali SE, Caprio S, Dziura J, et al. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes. 2008;57:367-371.
30. Thamer C, Machann J, Haap M, et al. Intrahepatic lipids are predicted by visceral adipose tissue mass in healthy subjects. Diabetes Care. 2004;27: 2726-2729.
31. Lemieux S, Despres JP, Moorjani S, et al. Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetologia. 1994;37:757-764.
32. Pascot A, Lemieux S, Lemieux I, et al. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profi le of premenopausal women. Diabetes Care. 1999;22:1471-1478.
33. Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460-468.
34. Ross R, Shaw KD, Martel Y, et al. Adipose tissue distribution measured by magnetic resonance imaging in obese women. Am J Clin Nutr. 1993;57:470-475.
35. Aucott LS. Influences of weight loss on long-term diabetes outcomes. Proc Nutr Soc. 2008;67:54-59.
36. Fox KA, Despres JP, Richard AJ, et al. Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91 246 ambulant patients in 27 European Countries. Eur Heart J. 2009;30:3055-3063.
37. Ko GT, Tang JS. Waist circumference and BMI cut-off based on 10-year cardiovascular risk: evidence for "central pre-obesity". Obesity (Silver Spring). 2007;15:2832-2839.
38. Raynor HA, Jeffery RW, Ruggiero AM, et al. Weight loss strategies associated with BMI in overweight adults with type 2 diabetes at entry into the Look AHEAD (Action for Health in Diabetes) trial. Diabetes Care. 2008;31:1299-1304.
39. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105-2120.
40. Ellis KJ, Grund B, Visnegarwala F, et al. Visceral and subcutaneous adiposity measurements in adults: influence of measurement site. Obesity (Silver Spring). 2007;15:1441-1447.
41. Warren M, Schreiner PJ, Terry JG. The relation between visceral fat measurement and torso level-is one level better than another? The Atherosclerosis Risk in Communities Study, 1990-1992. Am J Epidemiol. 2006;163: 352-358.
42. Gronemeyer SA, Steen RG, Kauffman WM, et al. Fast adipose tissue (FAT) assessment by MRI. Magn Reson Imaging. 2000;18:815-818.
43. Abate N, Garg A, Coleman R, et al. Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J Clin Nutr. 1997; 65:403-408.
44. Kantartzis K, Staiger H, Machann J, et al. Adiponectin oligomers and ectopic fat in liver and skeletal muscle in humans. Obesity (Silver Spring). 2009;17: 390-392.
45. Sarin S, Wenger C, Marwaha A, et al. Clinical significance of epicardial fat measured using cardiac multislice computed tomography. Am J Cardiol. 2008;102:767-771.
46. Wang CP, Hsu HL, Hung WC, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf). 2009;70:876-882.
47. Brennan DD, Whelan PF, Robinson K, et al. Rapid automated measurement of body fat distribution from whole-body MRI. Am J Roentgenol. 2005;185: 418-423.